论文部分内容阅读
2015年9月30日至10月5日,跨太平洋伙伴关系协议(TPP)12个成员国在美国亚特兰大举行最后一轮部长级谈判,各方围绕知识产权、市场准入、国有企业、投资等领域的关键分歧进行谈判,最终就TPP协议文本达成一致。TPP最后一轮谈判的主要内容(一)知识产权知识产权领域,TPP各成员国就新开发药品的专利保护期分歧较大。美国主张设置12年的药品保护期,从而使本国药企利润最大化;澳大利亚、日本等国则反对设置超过10年的药品保护期,
From September 30 to October 5, 2015, the 12 member nations of the Trans-Pacific Partnership (TPP) held the final round of ministerial-level negotiations in Atlanta, the United States. All parties focused on intellectual property rights, market access, state-owned enterprises, investment, etc. The key differences in the field of negotiations, and finally reached agreement on the text of the TPP agreement. Main contents of the last round of TPP negotiations (1) In the field of intellectual property rights in IPRs, TPP member countries differ greatly in the patent protection period of newly developed pharmaceutical products. The United States advocates setting a 12-year drug protection period so as to maximize the profits of its own pharmaceutical companies; Australia, Japan and other countries oppose setting a drug protection period of more than 10 years,